TrialThe Journal of antimicrobial chemotherapy2012

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.

Mark Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.